Baclofen safety study halted early: what we learned

NCT ID NCT02596763

Terminated Knowledge-focused Sponsor: University Hospital, Lille Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tracked 239 adults in France taking baclofen for alcohol use disorder. Researchers called participants monthly for a year to see how many stopped the drug due to side effects. The goal was to better understand which side effects are caused by baclofen versus other factors like alcohol or other medications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

alcohol abuse

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALCOHOL USE DISORDER

Contacts and locations

Show contact details

Locations

Centres de Soins, d'Accompagnement et de Prévention en Addictologie (CSAPA) Le Cèdre Bleu

Armentières, 59280, France
Etablissement Public de Santé Mentale (EPSM)

Lille, 59000, France
Hospital Center

Saint-Pol-sur-Ternoise, 62130, France
Hospital Center

Tourcoing, 59200, France
Hospital Center

Valenciennes, 59300, France
Hospital Center

Abbeville, 80100, France
Hospital Center

Arras, 62000, France
Hospital Center

Boulogne, 62200, France
Hospital Center

Carvin, 62220, France
Hospital Center

Clermont, 60600, France
Hospital Center

Dunkirk, 59300, France
Hospital Center

Ham, 80400, France
Hospital Center

Hazebrouck, 59190, France
Hospital Center

Lens, 62300, France
Hospital Center

Roubaix, 59100, France
Hospital Center

Saint-Amand-les-Eaux, 59230, France
Service d'Aide aux Toxicomanes (SATO-Picardie)

Beauvais, 60000, France
University Hospital of Caen

Caen, France
University Hospital of Rouen

Rouen, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.